Following the recent series of strong earthquakes in Italy, medical device company Sorin has published an update on its manufacturing operations in Mirandola, in the Northern Italian region of Emilia Romagna. The company reports that while no employees have been injured by the earthquakes, the firm’s Mirandola facility has experienced some damage with a subsequent temporary interruption in production.
Sorin develops, manufactures and markets medical technologies and innovative therapies for cardiac surgery and for the treatment of cardiac rhythm disorders. In the Mirandola plant, which is one of seven manufacturing sites of the Sorin Group worldwide, the company manufactures oxygenators and autotransfusion disposable kits, part of Sorin’s Cardiopulmonary Business Unit. The firm is currently working on the assessment of the structural integrity of the plant and on a plan to restore production.
As stated in the press release, the primary objective of the Sorin Group at this stage is to guarantee safety of its employees and ensure shipment of its products to healthcare professionals worldwide. The company will communicate further details regarding the degree of damage, the timing and the measures necessary to resume full operation as soon as possible. At this stage, the firm does not expect any impact on the company’s business performance in the long-term, while the short-term economic and financial impact is currently under analysis and will be promptly communicated.Yvonne Klöpping